Page last updated: 2024-09-04

s-carbamylcysteine and Parkinson Disease

s-carbamylcysteine has been researched along with Parkinson Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Mitchell, SC; Rawlings, L; Steventon, GB; Turton, L	1

Other Studies

1 other study(ies) available for s-carbamylcysteine and Parkinson Disease

Article	Year
Drug S-oxidation and phenylalanine hydroxylase: a biomarker for neurodegenerative susceptibility in Parkinson's disease and amyotrophic lateral sclerosis. Drug metabolism and personalized therapy, 2019, 04-02, Volume: 34, Issue:2 Topics: Adolescent; Adult; Aged; Amyotrophic Lateral Sclerosis; Biomarkers; Biotransformation; Cysteine; Female; Humans; Male; Middle Aged; Oxidation-Reduction; Parkinson Disease; Phenotype; Phenylalanine Hydroxylase; Polymorphism, Genetic; Young Adult	2019

Article

Year

Drug S-oxidation and phenylalanine hydroxylase: a biomarker for neurodegenerative susceptibility in Parkinson's disease and amyotrophic lateral sclerosis.

Drug metabolism and personalized therapy, 2019, 04-02, Volume: 34, Issue:2

Topics: Adolescent; Adult; Aged; Amyotrophic Lateral Sclerosis; Biomarkers; Biotransformation; Cysteine; Female; Humans; Male; Middle Aged; Oxidation-Reduction; Parkinson Disease; Phenotype; Phenylalanine Hydroxylase; Polymorphism, Genetic; Young Adult

2019